The CXC chemokines interleukin-8 and GRO/melanoma growth-stimulatory a
ctivity (GRO-alpha) are potent activators of neutrophils and lymphocyt
es, but also stimulate growth and differentiation of nonhematopoietic
cells like keratinocytes, fibroblasts, and melanocytes. High mRNA and
protein levels have been detected in psoriatic epidermis. Chemokine ac
tivation of target cells is mediated by specific receptors and two CXC
receptors have been described with similar affinity for interleukin-8
but different affinities for GRO-alpha, In this study, we examined th
e expression of both CXCR1 and CXCR2 in psoriatic tissue, identifying
the target cells of chemokine activation in psoriasis. By immunohistoc
hemistry and in situ hybridization, as confirmed by northern blot anal
ysis and reverse transcriptase polymerase chain reaction, we could det
ect expression of the CXCR2 in suprabasal lesional psoriatic keratinoc
ytes but not in healthy skin. The CXCR1 could not be localized in psor
iatic keratinocytes with immunohistochemistry and in situ hybridizatio
n, but infiltrating cells in the dermal compartment expressed both typ
es of receptors. These data suggest that in addition to neutrophil act
ivation by both CXCR1 and CXCR2, activation of keratinocytes mediated
by CXCR2 could contribute to the characteristic epidermal changes obse
rved in psoriasis.